Get the Stockscreener App
101.44
0.81%
0.815
Pre-market:
100.14
-1.30
-1.28%
Iradimed Corp stock is traded at $101.44, with a volume of 55,276.
It is up +0.81% in the last 24 hours and down -0.55% over the past month.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
See More
Previous Close:
$100.62
Open:
$100.5
24h Volume:
55,276
Relative Volume:
0.75
Market Cap:
$1.29B
Revenue:
$69.48M
Net Income/Loss:
$18.64M
P/E Ratio:
69.48
EPS:
1.46
Net Cash Flow:
$13.01M
1W Performance:
-1.59%
1M Performance:
-0.55%
6M Performance:
+44.69%
1Y Performance:
+78.06%
1-Day Range:
$99.82
$102.47
1-Week Range:
$98.90
$105.10
52-Week Range:
$47.48
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
101.44 | 1.28B | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
Allen Monty K sells IRADIMED (IRMD) shares worth $100,256 By Investing.com - Investing.com India
Allen Monty K sells IRADIMED (IRMD) shares worth $100,256 - Investing.com
Director Monty Allen Sells 1,000 Shares of iRadimed Corp (IRMD) - GuruFocus
IRADIMED Record Revenue Streak Supports 3870 Pump Rollout And Dividend Growth - Sahm
IRADIMED Dividend Hike Follows Record Revenue And New MRI Pump Rollout - Sahm
Iradimed Corp Eyes 2026 Surge After Strong Quarter - The Globe and Mail
iRadimed price target raised to $120 from $100 at Lake Street - TipRanks
IRadimed Corporation (NASDAQ:IRMD) Q4 2025 Earnings Call Transcript - Insider Monkey
How IRADIMED CORPORATION stock reacts to global recession fears2025 Geopolitical Influence & Weekly Setup with High ROI Potential - mfd.ru
Iradimed (IRMD) Earnings Beat With 26.8% Margin Tests High Valuation Narratives - Sahm
iRadimed (NASDAQ:IRMD) Hits New 12-Month High After Better-Than-Expected Earnings - Defense World
Why Iradimed Stock Soared Today - Yahoo Finance
Why Iradimed Stock Soared Today - The Motley Fool
iRadimed Corporation (NASDAQ:IRMD) to Issue Quarterly Dividend of $0.20 - MarketBeat
iRadimed Q4 Earnings Call Highlights - MarketBeat
Iradimed Co stock hits all-time high at 105.81 USD - Investing.com
IRadimed: Fourth Quarter Financial Highlights - Bitget
Earnings call transcript: Iradimed Co beats Q4 2025 forecasts, stock rises - Investing.com
IRMD Achieves Record Q4 Revenue with Strong Growth - GuruFocus
iRadimed (NASDAQ:IRMD) Sets New 12-Month High on Better-Than-Expected Earnings - MarketBeat
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q1 2026 Earnings Guidance - MarketBeat
IRadimed: Q4 Earnings Snapshot - kens5.com
iRadimed (NASDAQ:IRMD) Posts Earnings Results - MarketBeat
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results - TradingView
IRADIMED CORPORATION Reports Record Fourth Quarter and Full - GlobeNewswire
Uncovering Potential: iRadimed's Earnings Preview - Benzinga
Iradimed earnings on deck with 3870 pump launch in focus By Investing.com - Investing.com South Africa
Iradimed earnings on deck with 3870 pump launch in focus - Investing.com
Analysts Are Bullish on Top Healthcare Stocks: Iradimed (IRMD), Inotiv (NOTV) - The Globe and Mail
Ranger Investment Management L.P. Lowers Stake in iRadimed Corporation $IRMD - MarketBeat
The total return for IRADIMED (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years - Sahm
iRadimed (IRMD) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026 - stocktitan.net
Published on: 2026-02-02 13:48:08 - baoquankhu1.vn
Insider Transaction: Roger E Susi Sells $503K Worth Of iRadimed Shares - Benzinga
iRadimed (NASDAQ:IRMD) CEO Sells $503,250.00 in Stock - MarketBeat
IRADIMED Corp (NASDAQ:IRMD) Emerges as a Top Quality Stock from the Caviar Cruise Screen - Chartmill
IRADIMED CORPORATION's (NASDAQ:IRMD) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Iradimed stock hits all-time high of 104.67 USD - Investing.com
Insider Unloading: Roger E Susi Sells $509K Worth Of iRadimed Shares - Benzinga
How Record Q3 Results And FDA-Cleared MRI Pump Launch At IRADIMED (IRMD) Has Changed Its Investment Story - Sahm
Insider Selling: iRadimed (NASDAQ:IRMD) CEO Sells 5,000 Shares of Stock - MarketBeat
iRadimed (NASDAQ:IRMD) Hits New 52-Week HighStill a Buy? - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of “Moderate Buy” by Analysts - Defense World
iRadimed Corporation (NASDAQ:IRMD) Short Interest Update - MarketBeat
IRadimed Corporation (IRMD): Accelerating with Solid Capital Return - Yahoo Finance
iRadimed (NASDAQ:IRMD) Reaches New 52-Week HighHere's Why - MarketBeat
Iradimed stock hits all-time high at 100.55 USD - Investing.com
CEO Of iRadimed Makes $487K Sale - Benzinga
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):